Overview:
Increasing technological advances have the ability to impact many facets of drug development. Digital health technologies (DHTs) continue to improve the ability to reach more diverse patients, capture data continuously and passively outside traditional trial sites, and help create a more comprehensive understanding of patients' lived experiences. Therefore, it is critical to understand how to select the most fit-for-purpose technology to de-risk trial operations and regulatory approval.
Grounded in a measures-first approach, which puts the most meaningful aspects of health at the forefront of protocol development, this webinar will cover how to identify, select and implement digital health technologies using evidence-backed insights. The expert speakers will review recent regulatory guidance for the use of DHTs in clinical research and expand on existing frameworks and industry standards that allow for confident decision making in selecting fit-for-purpose technologies.
Attendees will learn:
- How to use evidence-backed insights to de-risk regulatory acceptance
- How to effectively identify measures that matter to patients
- How to identify fit-for-purpose digital health technologies and key considerations for deploying DHTs to improve patient outcomes and experience
Speakers:
Caprice Sassano, MPH
Caprice brings over a decade of experience in clinical research, and has spent the last four years building the Atlas Network and working closely with pharma customers to implement digital health technologies into clinical trials. As a Senior Outcomes Researcher, Caprice supports protocol review to aid in confident deployment of digital measures and technologies and vendor strategies, with a focus on providing insights from published evidence, clinical trial data and regulatory information. Joining 91黑料 by way of acquisition of the start-up HumanFirst, where she led the Applied Sciences team, her experience working closely with product, engineering and customer experience helped to build Atlas, the largest and most comprehensive network of DHTs and the evidence that support their use in clinical populations. Passionate about improving patient lives and measurement science, Caprice blends her background in public health epidemiology with her practical trial experience in an effort to create more inclusive, diverse and efficient trials.
Keith Thomas
Keith Thomas is a Senior Director on 91黑料’s Patient Centred Sciences team. In this role, Keith combines a deep technical understanding of DHTs with extensive experience in how they’re deployed and used by patients to inform 91黑料’s overall DHT strategy, and help clients design successful DHT implementations for their studies. Prior to joining 91黑料, he held a variety of engineering roles related to the design and development of medical devices and Digital Health Technologies, as well as multiple different product and program management positions focused on the evaluation, integration and deployment of DHTs in healthcare and research settings.